Health plans are taking steps to implement this promising payment system, but it sure ain’t easy
Health plan clinical administrators can take much better advantage of the low prices of pharmaceuticals that become untethered to a brand name
The program is not for everyone, but patients who qualify appear to have superior outcomes and lower costs
We invited experts from around the country to weigh in on the strengths and weaknesses of Hospital at Home and what would be required for the concept to succeed in nonintegrated health care settings.
How Rebates, Copayments, and Administration Costs Affect the Cost-effectiveness of Osteoporosis Therapies
Using case studies, researchers assess the effect of rebate rates on the cost-effectiveness of two oral bisphosphonates that are competing for tier 2 positioning
Stribild, a four-drugs-in-one agent, makes a once complex drug regimen more manageable with better outcomes
The idea is that selling policies across state lines will lower costs and increase the number of insured, but it hasn’t worked that way yet
With acquisition costs so low, pharmacies are almost giving away generic statins. How this affects the structure of the pharmacy benefit is yet to be determined.